LifeVantage Statistics
Total Valuation
LifeVantage has a market cap or net worth of $115.81 million. The enterprise value is $108.30 million.
| Market Cap | 115.81M |
| Enterprise Value | 108.30M |
Important Dates
The next estimated earnings date is Tuesday, October 28, 2025, after market close.
| Earnings Date | Oct 28, 2025 |
| Ex-Dividend Date | Sep 8, 2025 |
Share Statistics
LifeVantage has 12.69 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 12.69M |
| Shares Outstanding | 12.69M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | -1.29% |
| Owned by Insiders (%) | 21.21% |
| Owned by Institutions (%) | 57.72% |
| Float | 8.36M |
Valuation Ratios
The trailing PE ratio is 12.33 and the forward PE ratio is 9.11.
| PE Ratio | 12.33 |
| Forward PE | 9.11 |
| PS Ratio | 0.50 |
| Forward PS | 0.49 |
| PB Ratio | 3.32 |
| P/TBV Ratio | 3.40 |
| P/FCF Ratio | 11.12 |
| P/OCF Ratio | 9.84 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.05, with an EV/FCF ratio of 10.31.
| EV / Earnings | 11.05 |
| EV / Sales | 0.47 |
| EV / EBITDA | 7.05 |
| EV / EBIT | 8.88 |
| EV / FCF | 10.31 |
Financial Position
The company has a current ratio of 1.87, with a Debt / Equity ratio of 0.34.
| Current Ratio | 1.87 |
| Quick Ratio | 0.89 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 0.67 |
| Debt / FCF | 1.11 |
| Interest Coverage | 348.54 |
Financial Efficiency
Return on equity (ROE) is 32.34% and return on invested capital (ROIC) is 17.75%.
| Return on Equity (ROE) | 32.34% |
| Return on Assets (ROA) | 11.53% |
| Return on Invested Capital (ROIC) | 17.75% |
| Return on Capital Employed (ROCE) | 27.27% |
| Revenue Per Employee | $960,210 |
| Profits Per Employee | $41,197 |
| Employee Count | 238 |
| Asset Turnover | 3.46 |
| Inventory Turnover | 2.51 |
Taxes
In the past 12 months, LifeVantage has paid $2.44 million in taxes.
| Income Tax | 2.44M |
| Effective Tax Rate | 19.91% |
Stock Price Statistics
The stock price has decreased by -20.68% in the last 52 weeks. The beta is 0.29, so LifeVantage's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | -20.68% |
| 50-Day Moving Average | 11.90 |
| 200-Day Moving Average | 14.66 |
| Relative Strength Index (RSI) | 26.66 |
| Average Volume (20 Days) | 168,285 |
Short Selling Information
The latest short interest is 2.32 million, so 18.30% of the outstanding shares have been sold short.
| Short Interest | 2.32M |
| Short Previous Month | 2.48M |
| Short % of Shares Out | 18.30% |
| Short % of Float | 27.79% |
| Short Ratio (days to cover) | 14.15 |
Income Statement
In the last 12 months, LifeVantage had revenue of $228.53 million and earned $9.81 million in profits. Earnings per share was $0.75.
| Revenue | 228.53M |
| Gross Profit | 183.67M |
| Operating Income | 12.20M |
| Pretax Income | 12.24M |
| Net Income | 9.81M |
| EBITDA | 15.36M |
| EBIT | 12.20M |
| Earnings Per Share (EPS) | $0.75 |
Balance Sheet
The company has $20.20 million in cash and $11.68 million in debt, giving a net cash position of $8.52 million or $0.67 per share.
| Cash & Cash Equivalents | 20.20M |
| Total Debt | 11.68M |
| Net Cash | 8.52M |
| Net Cash Per Share | $0.67 |
| Equity (Book Value) | 34.64M |
| Book Value Per Share | 2.79 |
| Working Capital | 23.68M |
Cash Flow
In the last 12 months, operating cash flow was $11.88 million and capital expenditures -$1.37 million, giving a free cash flow of $10.51 million.
| Operating Cash Flow | 11.88M |
| Capital Expenditures | -1.37M |
| Free Cash Flow | 10.51M |
| FCF Per Share | $0.83 |
Margins
Gross margin is 80.37%, with operating and profit margins of 5.34% and 4.29%.
| Gross Margin | 80.37% |
| Operating Margin | 5.34% |
| Pretax Margin | 5.36% |
| Profit Margin | 4.29% |
| EBITDA Margin | 6.72% |
| EBIT Margin | 5.34% |
| FCF Margin | 4.60% |
Dividends & Yields
This stock pays an annual dividend of $0.18, which amounts to a dividend yield of 1.95%.
| Dividend Per Share | $0.18 |
| Dividend Yield | 1.95% |
| Dividend Growth (YoY) | 13.33% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 22.67% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 1.95% |
| Earnings Yield | 8.39% |
| FCF Yield | 8.99% |
Analyst Forecast
The average price target for LifeVantage is $30.50, which is 234.25% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.50 |
| Price Target Difference | 234.25% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 19, 2015. It was a reverse split with a ratio of 1:7.
| Last Split Date | Oct 19, 2015 |
| Split Type | Reverse |
| Split Ratio | 1:7 |
Scores
LifeVantage has an Altman Z-Score of 4.82 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.82 |
| Piotroski F-Score | 7 |